A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Men and women don’t experience pain the same way. Give someone an electric shock; bind a tourniquet tighter and tighter ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

For 20 years, doctors told Diana Falzone her pain was normal. “Well, that’s just how it is for some women,” she remembers one ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

AUSTIN, Texas, Sept. 20, 2024 /PRNewswire/ -- Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments ...

Before 1993, women were rarely included in clinical trials. Today, the medical field still doesn’t know how well many drugs ...